目前共有醫(yī)護(hù)人員23人，其中主任醫(yī)師3人（穆榮，趙金霞，鄧曉莉），副主任醫(yī)師2人（姚中強(qiáng)，劉蕊），主治醫(yī)師7人（張警豐,翟佳羽，金銀姬，劉暢，魏慧，李欣藝，柴靜），助理研究員1人（李常虹），主管技師1人（孫琳），技術(shù)員1人（安卓），所有臨床醫(yī)生均具有碩士以上學(xué)歷，9名護(hù)理人員均具有?？埔陨蠈W(xué)歷，其中主管護(hù)師2人（王振青，郭越）、護(hù)師3人（袁佳怡、夏云霞、果子婷）、護(hù)士4人（張東梅、劉久紅、高雅、趙微微）。穆榮主任全面主持科室工作，李常虹任黨支部書記，趙金霞、姚中強(qiáng)任科室副主任，王振青任護(hù)士長。

科室開設(shè)了硬皮病、類風(fēng)濕關(guān)節(jié)炎、系統(tǒng)性紅斑狼瘡以及強(qiáng)直性脊柱炎專病門診，并開展了免疫吸附治療重癥風(fēng)濕病、微循環(huán)檢查、尿酸晶體檢查及關(guān)節(jié)腔穿刺治療等診療項目，診治水平在全國處于較領(lǐng)先行列。全年門診量由2007年的1.3萬人次增加到2017年的近7萬人次。同時通過博客和微信平臺定期推送各類專業(yè)前沿進(jìn)展、會議筆記、科普知識等，定期開展患者教育，進(jìn)一步擴(kuò)大在患者及同行中的影響。

科研工作亦逐漸取得進(jìn)步?？剖乙灶愶L(fēng)濕關(guān)節(jié)炎，系統(tǒng)性紅斑狼瘡和脊柱關(guān)節(jié)病為主攻研究方向，先后有4人獲得國家自然科學(xué)基金課題共9項，北京市自然科學(xué)基金1項，并參與多項國家級及省部級研究項目?？剖易鳛榈谝蛔髡邌挝粎⑴c制定了中國的早期類風(fēng)濕關(guān)節(jié)炎分類標(biāo)準(zhǔn)，該論文獲得2016年度百篇中華醫(yī)學(xué)優(yōu)秀論文獎。共發(fā)表SCI論著40余篇，發(fā)表中文核心期刊論文近百篇，主編了《圖表式臨床風(fēng)濕病學(xué)》，并參編多部風(fēng)濕病專著。先后有多人次在國內(nèi)外專業(yè)學(xué)術(shù)會議上發(fā)言及壁報交流。2013年，我科成功申報國家臨床藥理實驗基地，可承擔(dān)任何一期臨床藥物觀察，目前已承擔(dān)10余項臨床藥物觀察項目。

TherheumatologyandImmunologyDepartmentoftheThirdHospitalofPekingUniversitywasfoundedin2006.

Atpresent,thereare25medicalstaff,including3chiefphysicians(MuRong,ZhaoJinxia,DengXiaoli),2deputychiefphysicians(YaoZhongqiang,LiuRui),and7chiefphysicians(ZhangJingfeng,ZhaiJiayu,jinyinji,LiuChang,WeiHui,LiXinyi,Chaijing),1assistantresearcher(LiChanghong),1technicianincharge(SunLin),1Technician(AnZhuo),allclinicianshavemaster'sdegreeorabove,9nursingstaffhavecollegedegreeorabove,including2Supervisor(WangZhenqing,GuoYue),3Seniornurses(YuanJiayi,XiaYunxia,GuoziTing),4nurses(ZhangDongmei,LiuJiuhong,GaoYa,ZhaoWeiwei).MuRongpresidedovertheworkoftheDepartment,ZhaoJinxiaandYaoZhongqiangasthedeputydirectoroftheDepartment,andWangZhenqingastheheadnurse.

TheDepartmentsetupgoutandrheumatoidarthritisclinic,andcarriedoutthetreatmentofsevererheumatismbyimmunoadsorption,microcirculationexamination,uricacidcrystalexaminationandjointcavitypuncture,thelevelofdiagnosisandtreatmentisintheleadingpositioninthecountry.Theannualoutpatientvolumeincreasedfrom13000in2007tonearly70000in2017.Atthesametime,throughtheblogandwechatplatform,weregularlypushforwardvariousprofessionalcutting-edgeprogress,meetingnotes,popularscienceknowledge,etc.,regularlycarryoutpatienteducation,andfurtherexpandtheimpactonpatientsandpeers.

Scientificresearchhasalsograduallyprogressed.Thedepartmentfocusesonrheumatoidarthritis,systemiclupuserythematosusandspondyloarthropathy.Fourofthemhaveobtained9NSFCprojectsand1BeijingNSFCproject,andparticipatedinmanynationalandprovincialresearchprojects.Asthefirstauthorunit,theDepartmentparticipatedinthedevelopmentofChina'searlyrheumatoidarthritisclassificationstandard,andthispaperwonthe2016annual100excellentpapersofChineseMedicineAward.OurdepartmenthaspublishedNearly30SCIpapers,nearly100Chinesecorejournalpapers,editedchartclinicalrheumatology,andparticipatedinthecompilationofmanyrheumatologymonographs.Manydoctorshavemadespeechesatprofessionalacademicconferencesathomelandandabroadandexchangedwithwallnewspapers.In2013,ourdepartmentsuccessfullyappliedforthenationalclinicalpharmacologyexperimentalbase,whichcanundertakeanyphaseofclinicaldrugobservation,andnowhasundertakenmorethan10clinicaldrugobservationprojects.